Takahashi et al. further found that during the remission phase of MS, CD95 expression increased on NK cells alongside decreased response of memory T cells, suggesting that CD95+ NK cells regulate autoimmune memory T cell responses during remission (31). Here, FAS is linked to myeloid sarcoma.